The treatment landscape of generalised myasthenia gravis, a prototypic antibody-mediated disorder of the neuromuscular junction, has considerably evolved in the past 8 years.1 The approval of targeted ...
CloudFirst Divestiture -- The sale of the CloudFirst business closed on September 11, 2025, for $40 million, removing an ...
President and CEO Doug Love outlined a series of anticipated clinical and regulatory milestones during the 25th Annual ...
April 7 (Reuters) - Fox Corp said on Tuesday it will integrate Kalshi's prediction market data across its news and streaming ...
A global peace advocate and founder of the Institute for Economics and Peace (IEP), Steve Killelea, has underscored the ...
Before AI, the sheer volume of data governments could collect had natural limits. Those limits no longer exist. That is the ...
Positive high-level results from a prespecified interim analysis of the I CAN Phase III trial showed that Ultomiris (ravulizumab) met its primary ...
Longhorn Vaccines and Diagnostics (LHNVD), an IND enabling-stage biopharmaceutical company, today announced it will present ...
Fox will integrate Kalshi forecasts across its news and streaming platforms as prediction markets gain mainstream media reach.
Annexon Biosciences (NASDAQ:ANNX) is one of the 10 Best Small-Cap Biotech Stocks According to Hedge Funds. The company’s ...
A new grant from the American Cancer Society (ACS) will fund research into a new strategy for targeting glioblastoma at MUSC ...
The Raw Materials Research and Development Council (RMRDC), has launched the second generation of its national database, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results